Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Factor XIII Deficiency: full-pipeline trial registry
A small indexed set (3 trials) with no open enrollment listed right now.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count
Factor XIII Deficiency: 3 US clinical trials tracked, none currently recruiting.
Factor XIII Deficiency is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is CSL Behring, running 2 of these trials.
Enrollment posture brief
Registry condition factor-xiii-deficiency
OPEN 0 | RECR 0% | LATE 1 | EARLY 1 | RANK #5209 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Factor XIII Deficiency has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Factor XIII Deficiency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Factor XIII Deficiency is recruiting below its size-band peers.
0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Clinical Trial of Factor XIII (FXIII) Concentrate
Children's Hospital of Orange County
NCT00640289
An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
CSL Behring
NCT00945906
A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency
CSL Behring
NCT00883090
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Factor XIII Deficiency records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Factor XIII Deficiency trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Factor XIII Deficiency page
3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Factor XIII Deficiency trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- CSL Behring sponsors the most Factor XIII Deficiency trials on record, review their full trial history before evaluating a specific study. See CSL Behring's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Factor XIII Deficiency condition card totals 3 registered trials; most-linked intervention FXIII Concentrate (Human); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.